Zobrazeno 1 - 10
of 25
pro vyhledávání: '"H, Keshtmand"'
Autor:
C. Charlois Ou, A. Faure, A. Fournier, D. Marteau, H. Keshtmand, L. Ezri, S. Quelet, P. Morin, G. Muller, F. Antoun
Publikováno v:
Revue des Maladies Respiratoires. 32:705-714
Resume Objectifs Le nombre de tuberculoses maladie a 12–18 mois, dans le cadre de l’activite de depistage au sein d’un centre de lutte antituberculeuse (CLAT), n’a pas ete decrit a notre connaissance en France, la majorite des autres pays n
Publikováno v:
La Revue de Médecine Interne. 30:955-962
Better understanding of the pathogenesis of tissue fibrosis, and especially the pivotal role of the extracellular matrix components, shed new light on the use of several immunosuppressive drugs to treat systemic sclerosis. We review the recent experi
Autor:
H Keshtmand, Laurence Michel, Ewn Levarht, Ewn Romijn, F Jean-Louis, Dominique Farge, F Verrecchia, J Baraut, Van, Laar, Jm, van, Pelt, J
Publikováno v:
Journal of Investigative Dermatology. 129:2523-2533
Autor:
A, Fournier, F, Antoun, C, Charlois Ou, G, Muller, L, Ezri, P, Morin, A, Faure, D, Marteau, H, Keshtmand, S, Quelet
Publikováno v:
Revue des maladies respiratoires. 32(7)
To our knowledge, the proportion of active tuberculosis diagnosed after 12-18 months during a screening tuberculosis process in a specialized centre (centre de lutte antituberculeuse [CLAT]) has not been described in France. The majority of other cou
Publikováno v:
La Revue de medecine interne. 30(11)
Better understanding of the pathogenesis of tissue fibrosis, and especially the pivotal role of the extracellular matrix components, shed new light on the use of several immunosuppressive drugs to treat systemic sclerosis. We review the recent experi
Autor:
A, Bourgarit, H-P, Mallet, H, Keshtmand, N, De Castro, J, Rambeloarisoa, O, Fain, F, Antoun, C, Picard, G, Rocher, D, Che, D, Farge, C, Pintado
Publikováno v:
La Revue de medecine interne. 30(10)
The impact of the TB-info software was assessed on the care of patients treated with antituberculosis regimen (ATT).Cohort study of patients with tuberculosis who received an ATT in 2004 in two hospitals and five medical centres in Paris. Follow-up w
Autor:
D, Farge, R, Porcher, F, Antoun, O, Fain, H, Keshtmand, G, Rocher, H-P, Mallet, J, Rambeloarisoa, F, Gerber, N, De Castro, D, Che, D, Coulombier, R, Zaleskis, J-L, Herrmann, C, Dye
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 11(9)
Tuberculosis (TB) is a persistent public health problem in European cities. France has been unable to report on treatment outcomes until now, and it is not known whether the World Health Organization (WHO) target cure rate of 85% has been met.All pat
Publikováno v:
La Revue de Médecine Interne. 28:40-41
Publikováno v:
Revue des Maladies Respiratoires. 29:A48
Publikováno v:
La Revue de Médecine Interne. 32:S128